Operating profit before deduction of amortization: Harmony Biosciences Holdings, Inc. (HRMY)
The development of orphan drugs to correct brain histamine activity creates a foundation for growth for Harmony Biosciences (HRMY). The EBITDA metric reflects net cash flow dynamics, where 243.12 determines this parameter level. The synergy between diagnostic centers and patient support programs guarantees customer loyalty, while strict patent control and FDA requirements block the expansion of smaller competitors.
Harmony Biosciences Holdings, Inc. - analytical breakdowns and key metrics (HRMY)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Capital Harmony Biosciences|HRMY - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Harmony Biosciences Inc|HRMY - Company Aggregate Debts|Debt to Book Capitalization Ratio Harmony Biosciences|HRMY - Company Long-Term Debts|Short-Term Debt Volume Harmony Biosciences|Immediate Liquidity harmonybiosciences.com
- earnings and market multiples details:
HRMY - Company Net Income|Company Profit Forecast Harmony Biosciences|HRMY - P/E Multiple|Projected Price to Earnings harmonybiosciences.com|HRMY - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Harmony Biosciences|HRMY - Operating profit EBITDA|Net earnings per one share for the last twelve months Harmony Biosciences|HRMY - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months harmonybiosciences.com|HRMY - Earnings growth in current year|Expected earnings per share growth for next year Harmony Biosciences
- sales and revenue data:
Summary company analytics:Harmony Corp (HRMY)
Harmony Biosciences monetizes patent-protected therapies for rare sleep disorders, leveraging stable patient demand. This metric captures the actual cash flow generated by the core business before interest and taxes. By analyzing the EBITDA trajectory, investors determine the efficiency of the operational structure's scaling. The upward curve confirms high product margins, while dips signal potential risks. Positive momentum serves as the foundation for long-term share price growth.
Who Harmony Biosciences competes with
Income before deduction of interest, taxes and amortization BIIB|NBIX - Profit before payment of interest, taxes and amortization|regencellbioscience.com (RGC) - Operating profit before deduction of amortization|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization ACADIA Pharma (ACAD)|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Operating profit before amortization VKTX (Viking Therapeutics Corp)|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX - Profit before interest, taxes and amortization|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization BHVN|Amylyx - Operating profit EBITDA|TRVI: Profit before payment of interest, taxes and amortization|PRAX: Operating profit EBITDA|AVXL - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization CeriBell|Profit before interest, taxes and amortization Prothena Corporation PLC PRTA|Profit before payment of interest, taxes and amortization Alector, Inc. (ALEC)|Operating income before deduction of amortization Annexon Biosciences Inc.|Operating profit EBITDA OMER (Omeros)|NGNE - Operating profit before deduction of amortization|AC Immune SA - Operating profit EBITDA|Operating income before deduction of amortization Voyager Therapeutics Inc VYGR|NMRA: Operating profit EBITDA|Profit before interest, taxes and amortization Scilex Holding Company, Inc. (SCLX)|Profit before payment of interest, taxes and amortization Tevogen Bio Holdings|Operating profit before amortization ACOG (Alpha Cognition Corp)|Operating profit EBITDA CGTX|Operating profit before deduction of amortization Inhibikase Therapeutics Inc IKT|Operating profit EBITDA SAVA (Cassava)|Assertio Holdings (ASRT) - Profit before interest, taxes and amortization|COYA - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Vistagen Therapeutics VTGN|OVID: Operating profit EBITDA|Acumen Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization CervoMed Inc|ATHE: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|Operating profit before deduction of amortization pepgen.com PEPG|Jupiter Neurosciences - Operating profit before deduction of amortization|Relmada Therapeutics Inc (RLMD) - Profit before interest, taxes and amortization|ANVS - Profit before payment of interest, taxes and amortization|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Operating profit before deduction of amortization NRSN|Operating profit EBITDA Reviva Pharmaceuticals Holdings Inc.|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS (NeurAxis Inc) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|Neuphoria - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NERV (Minerva Neurosciences Inc)|ATHA: Operating profit EBITDA|Addex (ADXN) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|CYCN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Operating profit before deduction of amortization pasitheaclinics.com KTTA|Profit before payment of interest, taxes and amortization Cortigent CRGT|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|BCLI - Profit before payment of interest, taxes and amortization|CARA (caratherapeutics.com) - Operating profit before amortization|CHRO (Chromocell Therapeutics Corp.) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization Eliem Therapeutics Inc. (ELYM)|Operating profit before deduction of amortization ITCI|LBPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MRNS|Profit before payment of interest, taxes and amortization NKGN (nkgenbiotech.com)|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating income before deduction of amortization Sage Therapeutics Inc. (SAGE)|SNPX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Trevena Inc|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|WENA - Operating income before deduction of amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
